BIOMX INC (PHGE) Fundamental Analysis & Valuation

NYSEARCA:PHGE • US09090D5095

6.81 USD
+1.06 (+18.43%)
At close: Mar 6, 2026
7.22 USD
+0.41 (+6.02%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PHGE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, PHGE scores 2 out of 10 in our fundamental rating. PHGE was compared to 520 industry peers in the Biotechnology industry. The financial health of PHGE is average, but there are quite some concerns on its profitability. PHGE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. PHGE Profitability Analysis

1.1 Basic Checks

  • PHGE had negative earnings in the past year.
  • In the past year PHGE has reported a negative cash flow from operations.
  • In the past 5 years PHGE always reported negative net income.
  • PHGE had a negative operating cash flow in each of the past 5 years.
PHGE Yearly Net Income VS EBIT VS OCF VS FCFPHGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of PHGE (-48.80%) is comparable to the rest of the industry.
  • The Return On Equity of PHGE (-96.91%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -48.8%
ROE -96.91%
ROIC N/A
ROA(3y)-69.25%
ROA(5y)-59.4%
ROE(3y)-352.46%
ROE(5y)-237.19%
ROIC(3y)N/A
ROIC(5y)N/A
PHGE Yearly ROA, ROE, ROICPHGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K

1.3 Margins

  • PHGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHGE Yearly Profit, Operating, Gross MarginsPHGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PHGE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PHGE has more shares outstanding
  • PHGE has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for PHGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHGE Yearly Shares OutstandingPHGE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
PHGE Yearly Total Debt VS Total AssetsPHGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • PHGE has an Altman-Z score of -9.59. This is a bad value and indicates that PHGE is not financially healthy and even has some risk of bankruptcy.
  • PHGE's Altman-Z score of -9.59 is on the low side compared to the rest of the industry. PHGE is outperformed by 71.54% of its industry peers.
  • PHGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.59
ROIC/WACCN/A
WACCN/A
PHGE Yearly LT Debt VS Equity VS FCFPHGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.66 indicates that PHGE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.66, PHGE is doing worse than 69.23% of the companies in the same industry.
  • PHGE has a Quick Ratio of 2.66. This indicates that PHGE is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.66, PHGE is not doing good in the industry: 66.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.66
PHGE Yearly Current Assets VS Current LiabilitesPHGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PHGE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.62% over the past year.
EPS 1Y (TTM)43.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PHGE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.00% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-834.26%
EPS Next 2Y-95.21%
EPS Next 3Y-33.04%
EPS Next 5Y12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHGE Yearly Revenue VS EstimatesPHGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
PHGE Yearly EPS VS EstimatesPHGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20 40 -40 60 80

More info and screens

Find the best growth stocksShow best growing peers

0

4. PHGE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHGE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHGE Price Earnings VS Forward Price EarningsPHGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHGE Per share dataPHGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

  • PHGE's earnings are expected to decrease with -33.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-95.21%
EPS Next 3Y-33.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHGE Dividend Analysis

5.1 Amount

  • PHGE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHGE Fundamentals: All Metrics, Ratios and Statistics

BIOMX INC

NYSEARCA:PHGE (3/6/2026, 8:04:00 PM)

After market: 7.22 +0.41 (+6.02%)

6.81

+1.06 (+18.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-19
Earnings (Next)05-13
Inst Owners17.74%
Inst Owner Change-96.95%
Ins Owners1.28%
Ins Owner Change0%
Market Cap10.83M
Revenue(TTM)N/A
Net Income(TTM)-18.57M
Analysts82.5
Price Target168.3 (2371.37%)
Short Float %10.96%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.96%
Min EPS beat(2)-0.76%
Max EPS beat(2)42.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)964.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1800%
EPS NY rev (1m)0%
EPS NY rev (3m)-1265.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)-29.64
EYN/A
EPS(NY)-20.2
Fwd EYN/A
FCF(TTM)-19.1
FCFYN/A
OCF(TTM)-19.09
OCFYN/A
SpS0
BVpS12.52
TBVpS4.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.8%
ROE -96.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.25%
ROA(5y)-59.4%
ROE(3y)-352.46%
ROE(5y)-237.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.66
Altman-Z -9.59
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3.92%
Cap/Depr(5y)40.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-834.26%
EPS Next 2Y-95.21%
EPS Next 3Y-33.04%
EPS Next 5Y12%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.42%
EBIT Next 3Y-6.28%
EBIT Next 5Y-1.39%
FCF growth 1Y-34.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.22%
OCF growth 3YN/A
OCF growth 5YN/A

BIOMX INC / PHGE FAQ

What is the fundamental rating for PHGE stock?

ChartMill assigns a fundamental rating of 2 / 10 to PHGE.


What is the valuation status of BIOMX INC (PHGE) stock?

ChartMill assigns a valuation rating of 0 / 10 to BIOMX INC (PHGE). This can be considered as Overvalued.


How profitable is BIOMX INC (PHGE) stock?

BIOMX INC (PHGE) has a profitability rating of 1 / 10.


Can you provide the financial health for PHGE stock?

The financial health rating of BIOMX INC (PHGE) is 5 / 10.